Home Alzheimer’s Disease Data from Phase IIb AIPAC Trial of Eftilagimod Alpha Shows Promise

Data from Phase IIb AIPAC Trial of Eftilagimod Alpha Shows Promise

Positive data from the randomized phase IIb AIPAC clinical trial of eftilagimod alpha (efti, LAG-31g, or IMP321) and paclitaxel (Abraxane) in HER2-negative, HR-positive metastatic breast cancer (MBC) was announced by Immutep.

The multicenter, placebo-controlled, double-blind study is evaluating eftilagimod alpha in combination with paclitaxel in a cohort of 277 patients with MBC to try and boost the T-cell immune responses against tumors.

“I am pleased to see this innovative chemo-immunotherapy approach in AIPAC is well tolerated by patients, while showing a numerically (non-significant) higher progression-free survival rate compared to chemotherapy alone,” AIPAC principal investigator Hans Wildiers, of the University Hospitals Leuven in Belgium, said in a press release. “Hormone receptor positive breast tumors represent the majority of metastatic breast cancer patients and…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

32 year old singer Tom Parker of The Wanted diagnosed with stage 4 glioblastoma

submitted by /u/Jexlan Continue Reading to the Source

Recent Comments